P875: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB-BORTEZOMIB-LENALIDOMIDE-DEXAMETHASONE REST STUDY

• Frida Bugge Askeland,
• Einar Haukås,
• Tobias S. Slørdahl,
• Anja Klostergaard,
• Tatjana Alexandersen,
• Diana Schjøll,
• Anna Lysén,
• Emil Hermansen,
• Fredrik Schjesvold

Affiliations

Frida Bugge Askeland

1 Oslo Myeloma Center, Oslo University Hospital, Department of Hematology, Oslo, Norway

Einar Haukås

3 Stavanger University Hospital, Department of Cancer and Blood Diseases, Stavanger, Norway

Tobias S. Slørdahl

4 St. Olavs Hospital, Department of Hematology, Oslo, Norway

Anja Klostergaard

5 Aarhus University Hospital, Department of Hematology, Denmark

Tatjana Alexandersen

1 Oslo Myeloma Center, Oslo University Hospital, Department of Hematology, Oslo, Norway

Diana Schjøll

1 Oslo Myeloma Center, Oslo University Hospital, Department of Hematology, Oslo, Norway

Anna Lysén

1 Oslo Myeloma Center, Oslo University Hospital, Department of Hematology, Oslo, Norway

Emil Hermansen

6 Copenhagen University Hospital, Rigshospitalet, Department of Hematology, Copenhagen, Denmark

Fredrik Schjesvold

1 Oslo Myeloma Center, Oslo University Hospital, Department of Hematology, Oslo, Norway